tbuckley/cabot-search huggingface dataset:
Remote Treatment of Panic Disorder: A Randomized Trial of Internet-Based Cognitive Behavior Therapy Supplemented With Telephone Calls
Authors: Per Carlbring, Susanna Bohman, Sara Brunt, Monica Buhrman, Bengt E. Westling, Lisa Ekselius, Gerhard Andersson
Journal: American Journal of Psychiatry (2006)

Objective: This study evaluated a 10-week Internet-based bibliotherapy self-help program with short weekly telephone calls for people suffering from panic disorder with or without agoraphobia. Method: After the authors confirmed the diagnosis by administering the Structured Clinical Interview for DSM-IV by telephone, 60 participants were randomly assigned to either a wait-listed control group or a multimodal treatment package based on cognitive behavior therapy plus minimal therapist contact via e-mail. A 10-minute telephone call was made each week to support each participant. Total mean time spent on each participant during the 10 weeks was 3.9 hours. The participants were required to send in homework assignments before receiving the next treatment module. Results: Analyses were conducted on an intention-to-treat basis, which included all randomly assigned participants. From pretreatment to posttreatment, all treated participants improved significantly on all measured dimensions (bodily interpretations, maladaptive cognitions, avoidance, general anxiety and depression levels, and quality of life). Treatment gains on self-report measures were maintained at the 9-month follow-up. A blind telephone interview after the end of treatment revealed that 77% of the treated patients no longer fulfilled the criteria for panic disorder, whereas all of the wait-listed subjects still suffered from it. Conclusions: This study provides evidence to support the use of treatment distributed via the Internet with the addition of short weekly telephone calls to treat panic disorder. Replication should be made to compare self-help and telephone treatment based on cognitive behavior methods with nonspecific interventions.
Massive acute hemodilution for incompatible blood reaction
Authors: O. A. Seager
Journal: JAMA (1974)

During emergency treatment for hemorrhagic shock, an acutely injured 15-year-old girl received 3,000 ml of ABO-incompatible blood. Hemolysis, abnormal clotting studies, renal shutdown, and severe hypotension developed rapidly. After being treated with extreme hemodilution, hypothermia, and exchange transfusion, she left the hospital asymptomatic 14 days after admission. To our knowledge, this is the first patient to have survived an acute transfusion reaction following a 3,000-ml transfusion of ABO-incompatible blood. (<i>JAMA</i>229:790-792, 1974)
Membrane-bound carbonic anhydrase IV is expressed in the luminal plasma membrane of the human gallbladder epithelium
Authors: S Parkkila
Journal: Hepatology (1996)

Alkaline hepatic bile is acidified in the gallbladder to prevent calcium precipitation and gallstone formation. Because membrane-bound carbonic anhydrase (CA) isoenzyme IV participates with cytoplasmic CA II in the acidification of urine in the kidney, we studied its expression in different regions of the human biliary tract using immunohistochemical techniques. The enzyme was expressed in the apical plasma membrane of the gallbladder epithelial cells and in the endothelium of the subepithelial capillaries. In the liver, some epithelial cells of the large bile ducts showed positive staining. Its presence in the gallbladder epithelium could be confirmed by Western blotting, which showed a single 35-kd polypeptide band, corresponding in molecular weight to the intact enzyme. The majority of the enzyme was phased to Triton X-114 detergent phase. A small amount of 35-kd polypeptide was also seen in the water phase. Smaller proteolytic fragments of the enzyme were not seen, suggesting that the tissue sample was well preserved. The results show that CA IV is expressed in abundance in the human gallbladder epithelium, where it may participate together with cytoplasmic CA II and ion transporters in acidification of the gallbladder bile via bicarbonate reabsorption.
Racial disparities in stage II prostate cancer outcomes in the Veterans Affairs hospital system.
Authors: D. Crockett, W. Gonsalves, T. Tashi, I. Aldoss, A. R. Sama, I. Al-Howaidi, X. Fang, P. Townley, S. Subbiah, P. T. Silberstein
Journal: Journal of Clinical Oncology (2010)

6119 Background: It is well known that black patients have worse outcomes than whites for prostate cancer due to multiple factors. We aim to assess whether racial disparities exist for prostate cancer outcomes within an equal access health care system like the Veterans Affairs (VA) hospitals. Methods: A retrospective analysis of blacks and whites with stage II prostate adenocarcinoma diagnosed between 1995 to 2005 via the Veterans Affairs Central Cancer Registry was conducted. Age, modality of treatment received, and race were studied with respect to overall survival by using log-rank and Kaplan-Meier analysis. Multivariate analysis was performed using Cox proportions hazards model. Results: A total of 62,967 patients with stage II prostate cancer were analyzed of which 26.7% were black. The 5-year survival was 74% for whites versus 72.1% for blacks (HR=1.090, 95%CI: 1.059-1.121; p<0.001). Subgroup analysis based on treatment modality used showed the following 5-year survival rates: No treatment (73.0%), Surgery (71.8%), Hormone (75.0%), Radiation (75.2%), Hormone + Radiation (77.3%); (p<0.001). The 5-year survival for patients <65 years of age on diagnosis was 76.0% versus 72.5% in patients >65 years of age (HR= 1.264, 95%CI: 1.228-1.299; p<0.001). Analysis based on race showed worse outcomes in blacks receiving surgery and no treatment (Table). Conclusions: In stage II prostate cancer, blacks did worse without treatment and with surgery compared to whites. Irrespective of race, patients who received a combination of hormone and radiation therapy lived longer and patients who received surgery did worse in terms of survival compared to patients not treated. Investigation into why these differences persist is warranted in future studies. Treatment (N) 5-yr survival p value HR 95% CI None (19,637) 73.0 1.000 White (14,314) 73.1 Black (5,323) 71.0 0.001 1.085 1.033-1.141 Surgery (15,673) 71.8 1.042 1.007-1.078 White (11,709) 72.3 Black (3,964) 69.3 <0.0001 1.121 1.059-1.187 Hormone (,8433) 75.0 0.931 0.893-0.970 White (6,117) 75.2 Black (2,316) 74.0 0.819 Radiation (12,915) 75.2 0.926 0.894-0.960 White (9,378) 75.2 Black (3,537) 73.5 0.105 Hormone + Radiation (6,309) 77.1 0.830 0.791-0.871 White (4,663) 76.9 Black (1,646) 77.2 0.817 No significant financial relationships to disclose.
Laval Médical, Quebec
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
First International Meeting on Cell Biochemistry and Function
Journal: JNCI Journal of the National Cancer Institute (1982)

Journal Article First International Meeting on Cell Biochemistry and Function Get access JNCI: Journal of the National Cancer Institute, Volume 69, Issue 4, October 1982, Page 987, https://doi.org/10.1093/jnci/69.4.987-f Published: 01 October 1982
Policlinico: Sezione Practica, Rome
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
New method uses magnetic resonance imaging, tumor's response to injury to monitor directly the effects of some anticancer drugs
Authors: C. A. Raymond
Journal: JAMA (1987)

A NEW METHOD that uses magnetic resonance imaging (MRI) to monitor, within 30 hours of treatment, the in vivo responses of tumors as small as a pinhead was reported by David F. Ranney, MD, at the Federation of American Societies for Experimental Biology meeting in Washington, DC. The technique soon may improve the use of chemotherapy. Chemotherapy is one of the major tools of the oncologist's trade, but its efficacy is hindered by the difficulty of predicting if an agent or combination of agents that works on patients' tumor cells in vitro will work in vivo. Current methods to monitor tumor responses clinically may take up to three weeks to determine if an agent is having an effect on all or any part of the tumor. This can delay instituting better therapy and permit drug-resistant cell lines to multiply. In a telephone interview, Ranney explained that he attached a magnetic
Medicina Cutanea, Barcelona
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Alternatives to Fluoroquinolones
Journal: JAMA (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cosmetic eye shadow mimicking orbital calcification
Authors: W. H. Forman
Journal: JAMA (1977)

<h3>To the Editor.—</h3> Orbital calcification is usually of two types, metastatic or dystrophic. The first is seen with abnormalities in calcium and phosphate metabolism, while the latter is caused by calcification within damaged tissues such as tumors, inflammation, infarcts, trauma, or degeneration. Calcifications may be intraocular or extraocular. When seen roentgenographically, some of the deposits are so typical as to suggest a correct cause, while others are less specific. Of more importance is the fact that calcification within the orbit is almost always abnormal and deserves further evaluation.<sup>1</sup>Because of this, we present a case of pseudocalcification of the orbit, which could initiate a long, needless workup. <h3>Report of a Case.—</h3> A 16-year-old girl came to Keesler Air Force Base Hospital with a two-month history of increasing headaches. The pain was described as "retro-ocular" and at times became so intense that "spots appeared before her eyes." Her past medical
Paint-remover hazard
Authors: R. D. Stewart
Journal: JAMA (1976)

The in-home use of paint removers containing methylene chloride results in the absorption of this solvent, which is metabolized to carbon monoxide. Exposure for two to three hours can result in the elevation of carboxyhemoglobin (COHb) to levels that stress the cardiovascular system. The metabolic formation of COHb continues following the paint-remover exposure, doubling the duration of the cardiovascular stress produced by a comparable COHb level after exposure to CO. Patients with diseased cardiovascular systems may not be able to tolerate this unexpected stress. (<i>JAMA</i>235:398-401, 1976)
Pathology of Fatal Bacterial Endocarditis: Before and Since Antibiotics
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Vanishing Pancreatic Calcification in Chronic Pancreatitis: Sign of Pancreatic Carcinoma
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Medical Education and State Boards of Registration
Journal: JAMA (1907)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Doctor
Authors: Joel Mattison
Journal: JAMA (1991)

There have been at least four recent films dealing with the young urban professional's examination of whether there is something behind the immediately apparent and external form of the world as we see it. Unfortunately, this quest is marred in all four explorations by two classic defects: the idea that this is an original or new quest and the failure to deal with the quest in terms of seeking to find a solution (or even implying that there could be one). The first film in the current series was<i>City Slickers</i>, which many suggested was only a variant of the midlife crisis theme. The second was<i>Regarding Henry</i>, in which a very successful lawyer is forced to reexamine everything about his life after a tragic and senseless shooting in a holdup. The third was<i>Doc Hollywood</i>, in which Michael J. Fox has to reexamine his planned pattern for success when
RUDIMENTS OF BIOCHEMISTRY
Journal: BMJ (1939)

the lower half.All the cells in the anterior column and in Clark's column of the grey substance of the spinal cord are completely filled with neurofibrils which extend into the axons and dendrites. (7)The area precentralis giganto pyramidalis (FAy) has progressed in differentiation beyond any other part of the cortex, and more especially that part of this area which determines movements of the upper part of the trunk and the muscles acting on the scapula and humerus.This volume is a valuable contribution to the morphology of the central nervous system, and the publication of succeeding sections of the work will be anticipated with much interest.
Public Health Reports, Washington
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal